Vikram Sheel Kumar Email

Co-Founder & CEO . Clear Creek Bio

Cambridge, MA

Location

Current Roles

Employees:
9
Revenue:
$1.4M
About
Clear Creek Bio is a private, clinical-stage biotech company focused on developing novel therapies to address infectious disease and cancer. The company’s lead drug candidate, brequinar, is a dihydroorotate dehydrogenase (DHODH) inhibitor with oral bioavailability and high potency. Clear Creek Bio is evaluating brequinar in clinical trials as a potential once-daily treatment for COVID-19. The company is also assessing brequinar as a potential treatment for acute myeloid leukemia.
Clear Creek Bio Address
585 Massachusetts Ave
Cambridge, MA
Clear Creek Bio Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.